From the Fibromyalgia (FMS) Global News Desk of Jeanne Hambleton
Pfizer, the manufacturers of Lyrica, the first fibromyalgia drug to be approved by the American Food & Drugs Associations (FDA), have decided to end human testing on a late-stage experimental drug, esreboxetine, which may have improved the cognitive function of patients with fibromyalgia. A [...]
Filed under: 13606, 16816416, 16816701, Awareness, Britain, British, CBS News, Clinical, Clinical Trials, Diseases, Drugs, FM, FM drug companies, FMS, FMS Global News, Feeds, Fibrohugs, Fibrohugs News, Fibromyalgia, Fibromyalgia Blogs, Fibromyalgia News UK, Fibromyalgia Press Releases, Health, Health Care, Health Insurance, Healthcare Quality, Jeanne Hambleton, Journalist UK, London, London UK, London UK Feed, Medical, Medical Research, News, News UK, News USA, Pharmacologic, Pharmacological, RSS, RSS Feeds, Research, Syndromes, US, USA, Washington D.C. City Feed, World, World News, World Wide, Worldwide, feed://feedproxy.google.com/bydls, http://feedburner.google.com/fb, http://feedburner.google.com/fbX | Tagged: Awareness, Clinical Trials, feed://feedproxy.google.com/bydls, Fibrohugs, Fibrohugs News, Fibromyalgia, Fibromyalgia News, Fibromyalgia News UK, Fibromyalgia News. FMS, Fibromyalgia patients, Fibromyalgia Research, Fibromyalgia Support, FM, FMS, FMS Global News, Global News, Health, http://feedburner.google.com/fb, Jeanne Hambleton, Journalist UK, London News, London UK, Lyrica, Medicine, News, News UK, Research | 1 Comment »